Skip to main content
Caplight Logo









Grapheal

Grapheal

Private
GrenobleHealthcare & Life Scienceshttps://grapheal.com/

Last Round

Grant

Feb 17, 2026

Total Funding Raised

$3.02M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Grapheal is a health technology and advanced manufacturing company that develops and manufactures flexible, graphene-based sensing systems for environmental, industrial, and healthcare markets.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials, Sensors, Environmental Monitoring

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

graphene biosensorssmart bandageremote patient monitoringmedtechpoint-of-care diagnosticsenvironmental monitoringwearable sensorsIoMTNFC/RFID sensorsbattery-free sensorsadvanced materialsPFAS detectiondigital test stripssweat analysiscustom sensor development

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Grapheal Comparables

Compare Grapheal with similar companies based on industry and business-model similarity.

Grapheal comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GraphWear Technologies Inc.
78%
Xsensio
77%
Ohmedics Ltd
76%

Grapheal Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 17, 2026
GrantFeb 12, 2025
GrantOct 6, 2022
SeedFeb 9, 2021
GrantNov 25, 2020
Grant
Jul 16, 2020

Key People

Founding team and executive leadership

François Amblard

Board Member, Interim CEO

Executive Team

Vincent Bouchiat

CEO and Co-founder at Grapheal SAS

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 22, 2026

    Grew 38% QoQ from 8 to 11 employees.

  • Feb 17, 2026

    Received grant funding from the European Innovation Council.

Grapheal Filings

Explore SEC and related filing metadata, where available.

Grapheal filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Grapheal's valuation, stock price, and market status.

Is Grapheal a public or private company?

Grapheal is a private company.

What is the current stock price of Grapheal?

Grapheal is a private company with no public stock price. No recent secondary market data is available.

How much is Grapheal worth (valuation)?

Valuation information for Grapheal is not publicly available.

Can I buy Grapheal stock?

Grapheal shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Grapheal's last funding round?

Grapheal's most recent funding round was Grant on February 17, 2026.

Who are the main investors in Grapheal?

Key investors in Grapheal include European Innovation Council, Électricité de France, Ministry of Higher Education and Research, EIT Health, National Academy of Medicine.

Will Grapheal IPO soon?

No public IPO plans have been announced for Grapheal.

How can I track Grapheal secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Grapheal's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersGrenoble
Employee Range9
Year Founded2019
Last FundingFeb 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?